Literature DB >> 10098644

Salinomycin-induced polyneuropathy in cats: morphologic and epidemiologic data.

J S van der Linde-Sipman1, T S van den Ingh, J J van nes, H Verhagen, J G Kersten, A C Beynen, R Plekkringa.   

Abstract

In April 1996, an outbreak of toxic polyneuropathy in cats occurred in the Netherlands. All cats had been fed one of two brands of dry cat food from one manufacturer. Chemical analyses of these foods, stomach contents, and liver and kidney of affected cats revealed contamination with the ionophor salinomycin. Epidemiologic and clinical data were collected from 823 cats, or about 1% of the cats at risk. In 21 affected cats, postmortem examination was performed. The affected cats had acute onset of lameness and paralysis of the hindlimbs followed by the forelimbs. Clinical and pathologic examination indicated a distal polyneuropathy involving both the sensory and motor nerves.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10098644     DOI: 10.1354/vp.36-2-152

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  17 in total

1.  Accidental salinomycin intoxication in calves.

Authors:  Arash Omidi; Mohammad R Aslani; Ahmad R Movassaghi; Mehrdad Mohri; Mohammad Dadfar
Journal:  Can Vet J       Date:  2010-10       Impact factor: 1.008

2.  Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice.

Authors:  Wolfgang Boehmerle; Hanna Muenzfeld; Andreas Springer; Petra Huehnchen; Matthias Endres
Journal:  J Mol Med (Berl)       Date:  2014-04-27       Impact factor: 4.599

3.  Retrospective study of salinomycin toxicosis in 66 cats.

Authors:  Akos Pakozdy; Iris Challande-Kathman; Marcus Doherr; Sigitas Cizinauskas; Simon J Wheeler; Anna Oevermann; Andre Jaggy
Journal:  Vet Med Int       Date:  2010-03-22

4.  Salinomycin efficiency assessment in non-tumor (HB4a) and tumor (MCF-7) human breast cells.

Authors:  Andressa Megumi Niwa; Gláucia Fernanda Rocha D Epiro; Lilian Areal Marques; Simone Cristine Semprebon; Daniele Sartori; Lúcia Regina Ribeiro; Mário Sérgio Mantovani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-03-02       Impact factor: 3.000

5.  P-glycoprotein limits oral availability, brain penetration, and toxicity of an anionic drug, the antibiotic salinomycin.

Authors:  Jurjen S Lagas; Rolf W Sparidans; Robert A B van Waterschoot; Els Wagenaar; Jos H Beijnen; Alfred H Schinkel
Journal:  Antimicrob Agents Chemother       Date:  2008-01-14       Impact factor: 5.191

Review 6.  Dissecting pharmacological effects of chloroquine in cancer treatment: interference with inflammatory signaling pathways.

Authors:  Lokman Varisli; Osman Cen; Spiros Vlahopoulos
Journal:  Immunology       Date:  2019-12-22       Impact factor: 7.397

Review 7.  Salinomycin: a novel anti-cancer agent with known anti-coccidial activities.

Authors:  Shuang Zhou; Fengfei Wang; Eric T Wong; Ekokobe Fonkem; Tze-Chen Hsieh; Joseph M Wu; Erxi Wu
Journal:  Curr Med Chem       Date:  2013       Impact factor: 4.530

8.  Acute idiopathic polyneuritis with spontaneous remission in an Abyssinian cat.

Authors:  Aurélien Jeandel; Kaspar Matiasek; Stéphane Blot
Journal:  Can Vet J       Date:  2015-12       Impact factor: 1.008

Review 9.  Salinomycin as a drug for targeting human cancer stem cells.

Authors:  Cord Naujokat; Roman Steinhart
Journal:  J Biomed Biotechnol       Date:  2012-11-21

10.  Dose-dependent adverse effects of salinomycin on male reproductive organs and fertility in mice.

Authors:  Olajumoke Omolara Ojo; Smrati Bhadauria; Srikanta Kumar Rath
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.